During my ERC starting grant project, my lab has identified small molecule inhibitors that inhibit the proliferation of MYB-dependent leukemia cell lines. In this proof of concept project, we aim to investigate the potential of th...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
Bcl-Inhib
Discovery of Bcl 3 inhibitors as Potential Chemopreventive A...
150K€
Cerrado
ONCODESTROYER
Targeting cancer vulnerabilities in acute leukemia
3M€
Cerrado
SAF2015-65113-C2-2-R
DESARROLLO PRECLINICO DE NUEVAS ESTRUCTURAS BIOACTIVAS MODUL...
85K€
Cerrado
POCUMINT
Proof Of Concept Use of MTH1 Inhibitors as New Treatments fo...
165K€
Cerrado
ChAMPioN
Game changing Precision Medicine for Curing All Myeloprolife...
3M€
Cerrado
Información proyecto MYBIN
Líder del proyecto
VIB VZW
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
238K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
During my ERC starting grant project, my lab has identified small molecule inhibitors that inhibit the proliferation of MYB-dependent leukemia cell lines. In this proof of concept project, we aim to investigate the potential of these compounds to be further developed as anti-cancer agents. We will determine their potential to inhibit the proliferation breast cancer and colon cancer cell lines and possible additional activity against other solid tumors. In addition, we will investigate the IP landscape and possibilities to improve the chemical properties. These pre-clinical data should provide the basis for the further development of these MYB inhibitors as anti-cancer agents.